Relay Therapeutics, Inc. (RLAY) Operating cash flow 2019–2025
Relay Therapeutics, Inc. (RLAY) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$235.5MFY2025 · since FY2019: -$66.1M → -$235.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$235.5M | +5.5% |
| FY2024 | -$249.1M | +17.1% |
| FY2023 | -$300.3M | -30.9% |
| FY2022 | -$229.5M | -208.4% |
| FY2021 | -$74.4M | +27.4% |
| FY2020 | -$102.5M | -55.0% |
| FY2019 | -$66.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice